| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Net sales | 205,634 | 203,121 | 196,606 | |
| Cost of sales | 57,111 | 63,588 | 61,553 | |
| Gross profit | 148,523 | 139,533 | 135,053 | |
| Acquisition related amortization and remeasurement | - | - | 6,521 | |
| Sales, general, and administrative | 148,102 | 136,493 | - | |
| Research and development | 14,774 | 15,934 | 17,294 | |
| General and administrative expense, total | - | - | 33,561 | |
| Selling and marketing expense, total | - | - | 96,576 | |
| Acquisition-related amortization, impairment, and remeasurement (note 11) | 2,693 | 3,109 | - | |
| Operating loss | -17,046 | -16,003 | -18,899 | |
| Interest expense, net | -4,681 | -3,950 | -5,210 | |
| Other (expense) income, net | -535 | 5,730 | -2,528 | |
| Loss before income taxes | -22,262 | -14,223 | -26,637 | |
| Income tax expense | 533 | -142 | 751 | |
| Net loss | -22,795 | -14,081 | -27,388 | |
| Currency translation adjustment | -274 | 3,464 | 1,829 | |
| Other comprehensive (loss) income, before tax | -274 | 3,464 | 1,829 | |
| Other comprehensive (loss) income, net of tax | -274 | 3,464 | 1,829 | |
| Comprehensive loss | -23,069 | -10,617 | -25,559 | |
| Earnings per share, basic | -0.57 | -0.36 | -0.71 | |
| Earnings per share, diluted | -0.57 | -0.36 | -0.71 | |
| Weighted average number of shares outstanding, basic | 39,766,000 | 39,501,000 | 38,488,000 | |
| Weighted average number of shares outstanding, diluted | 39,766,000 | 39,501,000 | 38,488,000 | |
Orthofix Medical Inc. (OFIX)
Orthofix Medical Inc. (OFIX)